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Abstract
Background: Environmental and lifestyle factors regulate the expression and release of immune mediators. It has
been hypothesised that ambient air pollution may be such an external factor and that the association between air
pollution and impaired glucose metabolism may be attributable to inflammatory processes. Therefore, we assessed
the associations between air pollution, circulating immune mediators and impaired glucose metabolism.
Methods: We analysed concentrations of 14 pro- and anti-inflammatory immune mediators as well as fasting glucose
and insulin levels in plasma of 363 women from the Study on the influence of Air pollution on Lung function,
Inflammation and Aging (SALIA, Germany). Exposure data for a group of pollutants such as nitrogen oxides (NO2,
NOx) and different fractions of particulate matter were available for the participants' residences. We calculated the
association between the pollutants and impaired glucose metabolism by multiple regression models.
Results: The study participants had a mean age of 74.1 (SD 2.6) years and 48% showed impaired glucose
metabolism based on impaired fasting glucose or previously diagnosed type 2 diabetes. Only long-term exposure
NO2 and NOx concentrations showed positive associations (NO2: OR 1.465, 95% CI 1.049-2.046, NOx: OR 1.409,
95% CI 1.010-1.967) per increased interquartile range of NO2 (14.65 µg/m3) or NOx (43.16 µg/m3), respectively, but
statistical significance was lost after correction for multiple comparisons. Additional adjustment for circulating immune
mediators or the use of anti-inflammatory medication had hardly any impact on the observed ORs.
Conclusions: Our results suggest that exposure to nitrogen oxides may contribute to impaired glucose metabolism,
but the associations did not reach statistical significance so that further studies with larger sample sizes are required
to substantiate our findings. Our data do not preclude a role of inflammatory mechanisms in adipose or other tissues
which may not be reflected by immune mediators in plasma.
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Introduction
Air pollution is a major environmental risk factor that
contributes to the development of a range of acute and chronic
conditions such as pulmonary and cardiovascular diseases
[1-4]. Novel data indicate that certain pollutants may also
contribute to impaired glucose metabolism and the
development of type 2 diabetes (T2D) [5-8]. Several
epidemiological studies and animal models support this
hypothesis by linking elevated levels of several pollutants, like
particulate matter (PM) and nitrogen oxides (NOx), to increased
diabetes incidence rates [6,8-11] and the development of
insulin resistance [12-15]. However, the data are still
controversial, because not all studies observed associations
between air pollution and risk of T2D [16].
Main contributors to air pollution are emissions from traffic
and industry. Fuels combust to elementary components and
volatile fumes of inorganic agents like nitrogen oxides, sulfur
dioxide or organic pollutants [17]. A structural characterisation
of all emitted agents is difficult due to the complex composition
of the fuels, the reactive potential of the intermediates and the
conditions of reaction in the engine or combustion chamber.
Physico-chemical reactions also take place after the emission,
and particulate matter (PM) can increase their diameter from
<0.1 µm (PM0.1, ultrafine particles) to up to around 1 µm by
aggregation. In contrast, coarse particles (PM coarse) between
2.5 and 10 µm in size can arise from mechanical processes like
abrasion or originate from sandstorms, volcanic eruption or
pollination [18].
There are two major hypotheses on how PM affects health.
First, according to Brown et al. [19] around 50% of the inhaled
particles are deposited in the lung and can induce a local
immune reaction. Due to the small size of the inhaled particles,
they are able to penetrate a large surface of the lung and can
enter deeply into the respiratory tract. The particles are
recognised as foreign matter, and local immune cells like
macrophages are activated. These cells can release
proinflammatory cytokines and chemoattractants [19-21]. This
inflammation aggravates by continued exposure to air pollution
and leads to locally elevated concentrations of proinflammatory
cytokines and chemokines in the lung. These immune
mediators are thought to ”spill over“ into the circulation and
trigger cellular inflammatory responses in different tissues. In
line with this hypothesis, increased concentrations of
proinflammatory acute-phase proteins, cytokines and
chemokines such as high-sensitivity C-reactive protein
(hsCRP) [22,23] or interleukin-8 (IL-8) [24] have been observed
in individuals with high exposure to ambient air pollution
compared with individuals who were less exposed. Second,
inhaled particles are able to cross cell membranes because of
their small diameter and enter the circulation [25,26]. This may
lead to the activation of immune cells in different tissues
throughout the body and both local and systemic inflammatory
processes. In addition, there is also some evidence that air
pollutants may activate pulmonary C fibres which could result
in the transmission of an inflammatory signal via the autonomic
system [27].
The relevance of proinflammatory mechanisms in the
development of T2D has been demonstrated extensively in
animal models as well as clinical and epidemiological studies
[28]. T2D is preceded not only by increased concentrations of
proinflammatory immune mediators in the circulation at 10 or
more years before its diagnosis [29-31], but also by an
upregulation of anti-inflammatory cytokines which most likely
represents a futile attempt to counterregulate immunological
and/or metabolic stimuli in this prediabetic period [32-34].
Despite the number of epidemiological studies linking
ambient air pollution and T2D, it is still not quite clear which
components of air pollution are associated with the
development of the disease, which pro- and anti-inflammatory
cytokines are induced and whether a spill-over of immune
mediators into the circulation explains this risk. Therefore, we
collected extensive exposure data within the Study on the
influence of Air pollution on Lung function, Inflammation and
Aging (SALIA, Germany) and measured a range of biomarkers
of subclinical inflammation in plasma samples of the study.
Using a cross-sectional study design we aimed (i) to assess
which components of air pollution were associated with
impaired glucose metabolism; (ii) to characterise the
associations between these exposures and biomarkers of
subclinical inflammation and (iii) to test the hypothesis that the
association between air pollution and impaired glucose
metabolism can be explained by inflammatory biomarkers in
the circulation.
Materials and Methods
Study design and population
The SALIA cohort study is based on consecutive cross-
sectional surveys that were performed between 1985 and 1994
as part of the Environmental Health surveys in North-Rhine
Westphalia (West Germany). Seven different study areas from
the highly industrialised Ruhr district [Dortmund (1985, 1990),
Duisburg (1990), Essen (1990), Gelsenkirchen (1986, 1990)
and Herne (1986)] were chosen to represent a range of
polluted areas with high traffic load as well as steel and coal
industries. Additionally two nearby nonindustrialised towns
[Borken (1985, 1986, 1987, 1990, 1993, 1994) and Dülmen
(1985, 1986)] were chosen as control areas with lower pollution
levels. All women aged 54–55 years who lived in the study
region were asked to participate; a total of 4,874 women (70%)
participated in the study [35]. Thus, the baseline of the study
was drawn from a random population of women aged 54-55
years living in the study area.
In the present study we used data from a follow-up
examination performed between 2008 and 2009. For this
follow-up all surviving women who participated in the baseline
investigation and who had a lung function measurement at
baseline were invited. In total, N=834 surviving women were
examined, and fasting blood samples were collected in a
subgroup of N=363 women. Written informed consent from all
study participants was collected. The study was approved by
the ethics committee of the Ruhr University in Bochum
(Germany).
Air Pollution, Inflammation and Glucose Metabolism
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e83042
The participants filled in an extensive questionnaire which
included items on symptoms and diagnoses of respiratory and
other chronic diseases. It also contained items on single-room
heating with fossil fuels and occupational exposures (dust,
gases and fumes; extreme temperatures). Socioeconomic
status was stratified into two categories by the maximum period
of education achieved by the women (<10 years vs. ≥10 years).
Women were also grouped according to their smoking habits
as never smokers, passive smokers (home, workplace), past
smokers, or current smokers (further categorised by <15, 15–
30, and >30 pack-years). Data about exposure to indoor mould
as covariable was also collected by the questionnaire.
Air pollution assessment
We applied Geographic Information System (GIS) technique
for the assessment of exposures. Using address coordinates
exposure to fine particles, nitrogen oxides and traffic was
estimated using three different methods:
First, data from monitoring stations maintained by the State
Environment Agency covering the Ruhr area in an 8-km grid
were used to reflect broad scale spatial variation in air quality.
Five-year means of 2003-2007 at the measurement stations for
PM10 (PM with diameter ≤10 µm) and NO2, which were located
nearest to the women’s home addresses, were used in order to
assess the air pollution exposure.
Second, we used land-use regression models [36-39] and
data from a measurement campaign (2008/2009) gained in the
framework of the ESCAPE study (European Study of Cohorts
for Air Pollution Effects) for assessment of individual long-term
exposure. Concentrations of pollutants were measured at 40
sites for NO2 and 20 sites for air-borne PM in the study area
based on fourteen-day samples for each season and site. The
validated land-use regression models were used to assign
estimated NO2, PM10, PM2.5 and filter absorbance of PM2.5
(soot) concentrations to each individual’s residential address
[39].
In SALIA we already found an association between diabetes
incidence and traffic-related exposure at baseline and shortly
afterwards [6]. Taking the results of this study into account we
anticipated that the incidence of diabetes is no immediate
effect of air pollution, but evolves after long-term elevated
exposures. Since air pollution in the Ruhr Area declined
considerably during the last decades we therefore also
assigned individually estimated exposure values which
describe exposure 10 to 20 years ago. For backextrapolation
we used an established ESCAPE procedure which is described
in detail in a manual published online (www.escapeproject.org).
For backextrapolation in time a background reference station
of the governmental monitoring system was chosen (‘Dortmund
Eving’ from LANUV [Federal Ministry of Food, Agriculture and
Consumer Protection]) which covered the period from one year
before the first SALIA baseline investigation (1984) to the last
day of the ESCAPE measurement campaign (October 15,
2009) and was in spatial relation to the SALIA cohort. The
means of PM10, NO2 and NOx for the ESCAPE measuring
period and for the period 12 months before to 12 months after
the baseline investigation of each SALIA cohort member were
calculated from daily and monthly means of PM10, NO2 and NOx
measured at this governmental reference station.
Backextrapolated concentration values for NO2, NOx, PM10,
PM2.5, PMcoarse and PMabsorbance were estimated by the ratio
method because PM concentrations proportionally declined
over time: For each woman the ratio baseline period/ESCAPE
period was multiplied with the concentration of the same
substance derived from land-use regression, PM10 ratio was
also multiplied with the fractions of PM10. The procedure is
explained in detail in the ESCAPE manuals
(www.escapeproject.eu).
Laboratory measurements
Fasting plasma samples were directly stored after collection
at -80° and used for all assays. Plasma insulin was measured
by ELISA (Mercodia, Uppsala, Sweden). Intra- and inter-assay
coefficients of variation for insulin were 2.6% and 3.0%,
respectively. Fasting plasma glucose and hsCRP were
determined on a Roche/Hitachi Cobas c 311 analyzer (Basel,
Switzerland). Plasma levels of IL-1 receptor antagonist (IL-1ra),
IL-6, IL-8, tumour necrosis factor α (TNFα), transforming
growth factor β1 (TGF-β1), total adiponectin, high-molecular-
weight (HMW) adiponectin, leptin, soluble E-selectin (sE-
selectin) and soluble intracellular adhesion molecule 1
(sICAM-1) were measured using Quantikine (IL-1ra, TGF-β1,
total adiponectin, HMW adiponectin, leptin, sE-selectin,
sICAM-1) or Quantikine HS (IL-6, IL-8, TNFα) ELISA kits (R&D
Systems, Wiesbaden, Germany). Plasma IL-18 was quantified
with the ELISA kit from MBL (Nagoya, Japan). Plasma
concentrations of macrophage chemoattractant protein-1
(MCP-1) and interferon gamma-induced protein 10 (IP-10)
were assessed using the Human Obesity Base Kit and the
Human Cytokine Custom Premix Kit A, respectively (R&D
Systems). Bead-based assays were performed using the Bio-
Plex 200 System controlled by Bio-Rad Bio-Plex Manager
Software 6.0 from Bio-Rad Laboratories (Hercules, CA).
Statistical Analysis
Descriptive statistics of population characteristics were
performed stratified by presence of impaired glucose
metabolism (IGM). IGM was defined using the ADA criteria for
impaired fasting glucose [40] or physician-diagnosed diabetes.
Women with a fasting glucose level below 100 mg/dl or without
a previous diagnosis of type 2 diabetes were assumed to have
normal glucose metabolism. Women who showed or exceeded
the 100 mg/dl glucose limit or were previously diagnosed with
T2D belonged to the case population. Continuous variables of
inflammation were skewed and therefore presented by median
and 25th/75th percentiles. We further performed Fisher’s exact
test for categorical variables and Wilcoxon test for continuous
variables to test for differences between the groups with and
without IGM.
Prior regression analysis we controlled the collected data for
normal distribution. Continuous variables of inflammation were
log-normally distributed and were transformed by the logarithm
to the base of 2. After performing multiple linear regression and
back-transformation of the regression coefficients, mean ratios
(MR) and 95% confidence intervals (CI) were presented. MR
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describe the relative change of the biomarker when the air
pollution exposure marker is increased by one unit. As unit we
chose the respective interquartile range (IQR), which is the
difference between the 75th quartile and the 25th quartile of the
distribution of the particle pollution variables.
Logistic regression was used to analyse the association
between air pollution exposure and the presence of IGM as
well as the association between biomarkers of inflammation
and the presence of IGM. Odds ratios with corresponding 95%
CI indicate the chance of having IGM if exposure to air pollution
is increased by one IQR or if the concentration of log2-
transformed inflammatory markers increase by one unit.
All P values are two-sided. P values <0.05 were considered
to indicate nominal statistical significance without correction for
multiple testing. In order to correct for multiple testing, we
adjusted the significance level in each analysis according to
Bonferroni (α = 0.05 divided by the number of comparisons). All
statistical analyses were performed using SAS version 9.3
(SAS Institute, Cary, NC).
Results
Characteristics of the study population
In our study population of 360 women, 174 (48.3%) had IGM
as defined by impaired fasting glucose (78.7% of women with
IGM) or a previous diagnosis of T2D by their physicians (21.3%
of women with IGM). Women with IGM had a higher BMI,
higher fasting glucose and insulin concentrations than women
without IGM, but did not differ with regard to age, education,
smoking status, place of residence (urban vs rural) or exposure
to indoor mould (Table 1).
Association between biomarkers of subclinical
inflammation and IGM
Plasma levels of 14 immune mediators for women with and
without IGM are presented with their median concentrations
and 25th and 75th percentiles in Table 2. In unadjusted
comparisons, we found higher concentrations for the acute-
phase protein hsCRP, the proinflammatory cytokine leptin, the
anti-inflammatory cytokine IL-1ra and the chemokine MCP-1/
CCL2 among women with IGM, whereas plasma levels of total
and HMW adiponectin were lower in IGM. There were no
differences between women without and with IGM with regard
to concentrations of IL-6, IL-18, TNFα, TGF-β1, IP-10/CXCL10,
IL-8/CXCL8 and sICAM-1 (all P>0.05).
We further analysed the association between circulating
immune mediators and IGM by multiple linear regression
adjusting for multiple confounders. As shown in Figure 1, high
levels of leptin, IL-1ra and MCP-1 were significantly associated
with IGM after adjustment for age, BMI, smoking status,
passive smoking, education, exposure to indoor mould and
season of blood sampling. For total and HMW adiponectin, the
inverse association remained significant after adjustment for
the aforementioned confounders (Figure 1). However, the
association between MCP-1 and IGM was only nominally
significant, but not after Bonferroni adjustment for multiple
testing.
We also obtained information about the medication of the
participants with non-steroidal anti-inflammatory drugs from the
questionnaire. Adding this information to the model had
virtually no effect on the results (data not shown).
Exposure to air pollution and IGM
Data for exposure to air pollution were collected from local
monitoring stations near the residence of the participants or
individually assigned from land-use regression estimates and
are summarised in Table 3 stratified by presence of IGM. In the
unadjusted analyses, exposure levels did not differ between
women without and with IGM. Only back-extrapolated NO2 and
NOx levels tended to be higher in women with IGM (P=0.16 and
P=0.11, respectively).
We also assessed the association between air pollution and
IGM by using logistic regression modeling. All exposure
variables were positively related to IGM after adjusting for age,
BMI, smoking status, passive smoking, indoor mould, years of
education and season of blood sampling (Table 4). In particular
nitrogen oxides showed a strong association with IGM. The
associations between both back-extrapolated NO2 (NO2†) and
back-extrapolated NOx (NOx†) and presence of IGM were
nominally statistically significant with an OR of 1.465 (95% CI
1.049–2.046, P=0.0249) and 1.409 (95% CI 1.011-1.967,
P=0.0437), respectively. However, it has to be noted that both
associations were not significant after Bonferroni adjustment
for multiple testing.
Table 1. Characteristics of the SALIA population stratified
by impaired glucose metabolism (IGM).
Variable
Impaired glucose
metabolism
Normal glucose
metabolism P
n 174 186 -
Age [years] 74.2 ± 2.7 73.9 ± 2.5 0.4065
BMI [kg/m2] 29.2 ± 4.7 26.1 ± 4.1 <0.0001
<10 years education [%] 35.3 31.9 0.5237
Smoking (current/former/
never) [%] 2.9/14.4/82.8 3.2/17.7/79.0 0.6817
Passive smoking [%] 54.6 61.3 0.2020
Exposure to indoor
mould [%] 12.6 13.4 0.8763
Urban residence [%] 54.0 52.7 0.8329
Fasting glucose [mg/dl] * 110.5 ± 12.0 91.2 ± 6.0 <0.0001
Fasting insulin [µU/ml] * 8.6 ± 3.9 6.2 ± 3.6 <0.0001
HOMA-IR * 2.4 ± 1.2 1.4 ± 0.9 <0.0001
Previous diagnosis of
T2D [%] 21.3 - <0.0001
Data are given as mean ± SD or percentages.
* Based on 137 women without previous diagnosis of T2D in the IGM group. BMI,
body mass index; HOMA-IR, homeostasis model assessment-insulin resistance;
T2D, type 2 diabetes.
doi: 10.1371/journal.pone.0083042.t001
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Impact of immune mediators on the association
between nitrogen oxides and IGM
After we examined the association between air pollution and
IGM, we tested if the significant association between NO2† and
IGM was independent of circulating immune mediators.
Therefore we extended the adjustment model separately for
each of the measured immune mediators. Figure 2 shows how
each immune mediator influenced the OR between NO2† and
IGM. By adjusting the association for the standard set of
confounders the OR is given by 1.465 (95% CI 1.049–2.046).
Additional adjustment for each of the analysed immune
mediators had virtually no effect on the observed OR (Figure
2). Similar results were obtained for the analogous analysis for
NOx† (Figure S1).
Table 2. Plasma concentrations of biomarkers of subclinical
inflammation stratified by the presence of impaired glucose
metabolism (IGM).
Biomarker
Impaired glucose
metabolism
Normal glucose
metabolism P* P**
Acute-phase protein     
hsCRP [mg/dl] 0.3 (0.2; 0.5) 0.2 (0.1; 0.4) 0.0019 0.0008
Proinflammatory
cytokines     
IL-6 [pg/ml] 1.6 (1.0; 2.5) 1.4 (0.9; 2.2) 0.2868 0.3113
IL-18 [pg/ml] 250.6 (197.5;325.6)
237.1 (185.5;
308.0) 0.6578 0.5457
TNFα [pg/ml] 1.4 (1.0; 2.0) 1.4 (1.0; 1.9) 0.8703 0.7904
Leptin [ng/ml] 19.6 (13.6; 27.6) 13.1 (8.0; 20.7) <0.0001 <0.0001
Antiinflammatory
cytokines     
IL-1ra [pg/ml] 268.7 (194.7;402.7)
210.2 (159.5;
275.6) <0.0001 <0.0001
TGF-β1 [ng/ml] 5.7 (3.8; 8.2) 5.4 (3.5; 8.3) 0.9053 0.8479
Total adiponectin
[µg/ml] 7.9 (5.1; 10.9) 9.5 (6.8; 13.0) 0.0001 <0.0001
HMW adiponectin
[µg/ml] 3.8 (2.4; 5.5) 5.1 (3.2; 7.1) <0.0001 <0.0001
Chemokines     
MCP-1/CCL2 [pg/ml] 136.6 (115.6;167.9)
131.8 (105.2;
163.3) 0.0108 0.0068
IP-10/CXCL10 [pg/ml] 47.2 (31.9; 71.1) 47.2 (31.5; 68.9) 0.4812 0.4755
IL-8/CXCL8 [pg/ml] 11.9 (9.4; 15.2) 11.3 (9.1; 15.2) 0.1583 0.1242
Soluble adhesion
molecules     
sE-selectin [ng/ml] 29.1 (22.0; 39.1) 27.5 (21.1; 32.7) 0.0655 0.0864
sICAM-1 [ng/ml] 210.4 (184.2;255.1)
218.2 (185.8;
264.6) 0.5342 0.4313
Data are given as median (25th percentile; 75th percentile).
*P values for the unadjusted comparison of both groups; **P values for the
comparison of both groups adjusted for age, BMI, smoking status, passive
smoking, education, exposure to indoor mould and season of blood sampling.
Based on 14 comparisons, the Bonferroni-adjusted P value to indicate statistical
significance after correction for multiple testing is 0.05/14 = 0.0036.
doi: 10.1371/journal.pone.0083042.t002
In order to better understand why this additional adjustment
had hardly any impact on the OR for the association between
nitrogen oxides and IGM, we used multiple linear regression
and assessed the association between NO2† as continuous,
independent variable and each immune mediator. As shown in
Figure 3, most immune mediators were not significantly
associated with NO2†, and only leptin showed a weak positive
association, whereas weak inverse association were observed
for TNFα and IP-10/CXCL10. P values for these associations
were between 0.01 and 0.05 and thus only nominally
significant, but not after correction for multiple testing leading to
a significance level of 0.05/14 = 0.0036. Results were similar
for NOx† (Figure S2).
Discussion
This cross-sectional study examined the association
between ambient air pollution, subclinical inflammation and
IGM in elderly women. Our main findings were as follows: (i)
Ambient levels of NO2 and NOx, but not of PM, were nominally
significantly associated with IGM, but not after adjustment for
multiple comparisons. (ii) The observed effect sizes were
independent of plasma levels of biomarkers of subclinical
inflammation. (iii) In line with this, we found associations
between subclinical inflammation and IGM, whereas
associations between nitrogen oxides and subclinical
inflammation were less pronounced.
Several studies demonstrated the influence of air pollution on
the prevalence or the prospective risk of T2D or hallmarks of
the disease like insulin resistence. One important class of
pollutants is the group of nitrogen oxides (NOx and NO2). Their
concentrations correlate with traffic load which means that their
sources are predominantly combustion processes in cars
[6,18,41,42]. With respect to adverse health effects NO2 and
NOx represent commonly studied nitrogen compounds. It was
shown that NO2 is related to the impairment of glucose
metabolism at relatively high [6,9] and low [5,8,43]
concentrations. The development of IGM is a continuous and
progressive process which can last many years before T2D is
manifest or diagnosed. Our prior study in women also based on
the SALIA cohort reported a 42% increase in the diabetes
incidence rate per IQR of PM or NO2 in a study population with
a baseline exposure to NO2 of 47 µg/m3. These results were
corroborated by two more recent studies. One study was based
on women in the United States. The main finding was a 24%
higher incidence rate for diabetes for an increase of ambient
NO2 concentrations by 11 µg/m3 (baseline exposure 43 µg/m3)
[9]. The second study was established in Denmark and started
1993 with more than 50,000 men and women. Even if the
overall NO2 concentration (15 µg/m3) was lower compared to
the German SALIA and American cohorts, the authors
confirmed the described association between increased
diabetes incidence rates for increasing NO2 levels [8]. Our
results are in line with these previously published results and
strengthen the notion of adverse metabolic health effects of
elevated traffic-related nitrogen oxides. NO2 has also been
examined in the context of diabetes-related mortality rates in a
large Danish cohort with the main finding of a strong
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association between the mortality rate and increasing levels of
ambient NO2 [43].
A second class of pollutants that has been investigated as
potential risk factor comprises PM of different particle sizes. In
our study, different exposure measures of PM showed no
significant association with IGM. This is in contrast to an
Iranian study [13] which examined the influence of lifestyle and
environmental factors on the health of children. Their results
suggest that exposure to elevated PM10 levels contributes to
the development of T2D by exacerbating insulin resistance,
measured as HOMA-IR. However, it has to be noted that
compared to our study, the exposure levels of PM10 were much
higher (122 ± 44 µg/m3) which may explain a more pronounced
effect. In a study from Taiwan [44] it was shown that long-term
exposure to PM2.5 contributed to a dysregulation of glucose
metabolism, assessed as elevated levels of HbA1c and fasting
glucose. In line with this, a rise of the T2D incidence rate by 1%
was observed if the concentration of PM2.5 increased by 10
µg/m3, even at relatively low levels in a study from the United
States [7]. These results are corroborated by a study from
Canada, which found an 11% increased T2D incidence rate by
a 10 µg/m3 increased PM2.5 level in a cohort of more than
60,000 participants [11]. Recent reports underline the
toxicological potential and importance of PM2.5 [4] for a
decrease of insulin sensitivity even after sub-acute exposure to
low levels of 5-10 µg/m3 PM2.5 [12]. However, it has to be noted
Table 3. Exposure to traffic-related air pollution stratified by
presence of impaired glucose metabolism.
Variable
Impaired glucose
metabolism
Normal glucose
metabolism P
NO2* [µg/m3] 29.1 ± 8.3 28.5 ± 7.7 0.42
NO2† [µg/m3] 39.7 ± 10.9 37.8 ± 9.8 0.16
NOx* [µg/m3] 47.8 ± 20.0 45.6 ± 19.4 0.21
NOx† [µg/m3] 74.1 ± 31.2 69.3 ± 30.0 0.11
PM2.5 absorbance* [10-5/m] 1.5 ± 0.5 1.5 ± 0.5 0.88
PM2.5 absorbance† [10-5/m] 2.9 ± 0.9 2.8 ± 0.8 0.88
PM2.5* [µg/m3] 17.9 ± 1.4 18.0 ± 1.4 0.56
PM2.5† [µg/m3] 34.0 ± 3.2 34.0 ± 3.1 0.74
PM coarse* [µg/m3] 9.6 ± 1.6 9.6 ± 1.8 0.89
PM coarse† [µg/m3] 18.2 ± 3.3 18.2 ± 3.3 0.79
PM10* [µg/m3] 27.0 ± 2.1 27.1 ± 2.3 0.89
PM10† [µg/m3] 51.2 ± 4.9 51.0 ± 4.9 0.90
Data represent mean ± SD.
* Measured within the observation period (2008/2009) by local air quality
measurement stations and calculated for the participants’ residence by LUR
model.
† Back-extrapolated concentrations of exposure variables (see section “Air
pollution assessment”).
doi: 10.1371/journal.pone.0083042.t003
Figure 1.  Association between circulating immune mediators and IGM.  Odds ratios are adjusted for age, BMI, smoking status,
passive smoking, education, exposure to indoor mould and season of blood sampling.
doi: 10.1371/journal.pone.0083042.g001
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that other studies were not able to confirm the association
between nitrogen oxides or PM and IGM [5,16]. These studies
were performed in rural areas with comparatively low pollution
levels, which may be the cause of the non-significant findings,
because lower effect sizes for lower exposure levels require
considerably larger cohorts to obtain the same statistical power
as a study with larger effect sizes at higher exposure levels.
Although our findings are only nominally significant, but not
after adjustment for multiple comparisons, the observed effect
sizes are in line with previous reports on the toxicological effect
of air pollution and in particular on potential associations
between nitrogen oxides and IGM [5,6,8,9,43]. Besides this
result there were no consistent associations between air
pollution and the dysregulation of biomarkers of subclinical
inflammation. We observed inverse assocations between the
exposure to air pollutants and the proinflammatory cytokine
TNFα and the chemokine IP-10. This might be related to a
decreased immune response of the elderly participants,
because both mediators are originally released by TH1 immune
cells. One can speculate that the advanced age of our study
population could have diminished the immune response.
The positive and significant association between NO2† and
circulating leptin could indicate a pulmonary inflammation [45],
if those levels are connected to the leptin concentrations in the
lung and respond in line with the first hypothesis. The
infiltration of the circulating system by solid pollutants shows
some parallels to microparticles, derived from endothelial or
apoptotic cells, which might accelerate the inflammatory
process. Those endogenous remnants increase in vitro the
ICAM-1 and VCAM-1 concentration and their mRNA levels,
which might be the result of activating the MAP kinase pathway
[46]. However, we were not able to detect any positive
association between PM2.5 or PM10 with sICAM-1 levels like
former studies [47]. Furthermore, we wanted to study the
influence of inflammation on the association between air
pollution and IGM. Therefore we added the single inflammatory
Table 4. Adjusted odds ratios (OR) and 95% confidence
intervals (CI) for the association between components of air
pollution and presence of IGM.
  OR (95% CI)  
Pollutant
Back-extrapolated
variables P*
Variables from the
survey 2008/2009 P*
NO2 1.465 (1.049-2.046) 0.0249 1.218 (0.909-1.630) 0.1862
NOx 1.409 (1.010-1.967) 0.0437 1.224 (0.926-1.617) 0.1562
PM2.5
absorbance 1.258 (0.947-1.670) 0.1127 1.110 (0.889-1.385) 0.3556
PM2.5 1.149 (0.812-1.627) 0.4331 1.117 (0.808-1.543) 0.5034
PM coarse 1.128 (0.794-1.603) 0.5004 1.075 (0.833-1.388) 0.5781
PM10 1.209 (0.871-1.679) 0.2561 1.145 (0.896-1.465) 0.2794
Odds ratios are standardised to one IQR increase of exposure variables and
adjusted for age, BMI, smoking status, passive smoking, education, exposure to
indoor mould and season of blood sampling.
* Based on 12 comparisons, the Bonferroni-adjusted P value to indicate statistical
significance after correction for multiple testing is 0.05/12 = 0.0042.
doi: 10.1371/journal.pone.0083042.t004
mediators separately into the model assessing the association
between NO2† and IGM, but the strength of the assosication
remained almost unchanged.
Previously published reports on the association between air
pollutants and systemic inflammation in human study
populations were inconsistent. Seaton et al. described an
assocation between fine particles like PM10 and the acute-
phase protein CRP in elderly people [48]. This finding was
confirmed by studies in children [10] and elderly men [47].
Rückerl et al. also found a relationship between elevated levels
of NO2, carbon monoxide and ultrafine particles and increased
circulating CRP levels [47]. Moreover, several studies reported
associations between PM and the proinflammatory cytokine
IL-6 [10,12,20,49]. In contrast, Seaton et al. were not able to
detect an effect of PM10 on IL-6 plasma concentrations [48],
which was also absent in a study in mice by Fonken et al. [50].
Also the association between PM and CRP could not be
supported by all studies [23,51].
Besides the male cohort of Seaton et al. [48], all other
mentioned cohorts included participants who were younger
than in the SALIA study. We cannot exclude a survivor effect in
our cohort. This means that it is possible that women who were
more susceptible to air pollution and therefore showed a more
intensive immune reaction were not included in our study any
more, because they mave have died earlier or may have been
too ill to participate in the study. An alternative explanation of
our null results regarding the role of biomarkers of subclinical
inflammation in the link between air pollution and glucose
metabolism might be that our elderly participants might have
been affected to various degrees by different age-related
chronic diseases, which are mostly proinflammatory so that the
level of circulating immune mediators may be less affected by
exogenous stimuli.
Our study has several strengths and limitations that should
be discussed briefly. This is the first study which investigates
the association between air pollution, plasma levels of
inflammatory biomarkers and IGM using extensive measures of
air pollutants and a detailed immunological phenotyping of
study participants. Our results are consistent with previously
published studies on the associations between nitrogen oxides
and IGM.
We are limited in the conclusions, because we performed a
cross-sectional study. Our sample size was moderate, so that
we cannot exlude that we may have missed associations that
would have been significant in larger cohorts. We only
examined elderly women so that a bias in certain findings due
to a survivor effect cannot be excluded. Data regarding the
prevalence of gestational diabetes as risk factor for subsequent
IGM in later life were not available. Oral glucose tolerance tests
were not performed in the study, so women with impaired
glucose tolerance who would also have been included in the
IGM group could not be diagnosed by their 2-hour glucose
levels. Moreover, data for HbA1c were not available so that
HbA1c levels could not be included in the definition of IGM.
The lack of an effect for PM may partly be due to the fact that
twice as many calibration sites were used for NO2 than for PM.
This may have weakened the ability of the particle model to
represent local traffic particles, which decline to urban
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background within 100 m. The out-of-sample R2 of the different
models for the Ruhr Area, however, were quite high and
comparable (NO2: 89%, PM2.5: 86%, PM2.5 absorbance: 97%,
PM10: 69%). Thus, differential measurement error from this
source might not be an explanation for the difference in effects.
Finally, we examined the effects of various exposure measures
separately, although everybody is exposed to a mixture of
particles. It is conceivable that all components of air pollution
have detrimental effects on health in their mixture which argues
for the use of more complex regression models to take additive
or synergistic effect of various pollutants into account [9]. It
should be noted that the systemic inflammatory markers were
evaluated at the same point in time as IGM. The latter may
have developed after long-term exposure to elevated air
pollution during the last decades. In contrast the inflammatory
markers might reflect a reaction after a more short-term
exposure. The exposure in 2008/2009 was much lower than
the exposure at study baseline and may not be associated with
systemic inflammatory reactivities any more.
In conclusion, we provide evidence that air pollution may be
linked to IGM with more pronounced associations for nitrogen
oxides than for PM. However, it should be noted that our
results were not robust against adjustment for multiple
comparisons. Therefore, further studies, preferably with larger
sample sizes and using a prospective design, will be necessary
to clarify to what extent air pollution and IGM are associated.
Although we observed some nominally significant associations
between between the up- and downregulation of pro- and anti-
inflammatory mediators and IGM, plasma levels of these
immune mediators did not explain the association between
exposure to NO2 or NOx and IGM. Our results do not preclude
the relevance of local inflammatory processes in adipose tissue
or the skeletal muscle which may be triggered by exposure to
air pollution and which may contribute to the development of
Figure 2.  Impact of adjustment for immune mediators on the relationship between IGM and NO2†.  *Adjusted for age, BMI,
smoking status, passive smoking, education, exposure to indoor mould and season of blood sampling.
All additional models are adjusted for the aforementioned covariables and the immune mediator indicated on the x-axis.
doi: 10.1371/journal.pone.0083042.g002
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IGM. Therefore, further mechanistic studies are required to
unravel to role of immune activation in the association between
air pollution and risk of T2D.
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